Synthesis of purine modified 2'-C-methyl nucleosides as potential anti-HCV agents. 2011

Hong-wang Zhang, and Longhu Zhou, and Steven J Coats, and Tamara R McBrayer, and Phillip M Tharnish, and Lavanya Bondada, and Mervi Detorio, and Sarah A Amichai, and Melissa D Johns, and Tony Whitaker, and Raymond F Schinazi
Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.

Based on the anti-hepatitis C activity of 2'-C-methyl-adenosine and 2'-C-methyl-guanosine, a series of new modified purine 2'-C-methyl nucleosides was prepared as potential anti-hepatitis C virus agents. Herein, we report the synthesis of both 6-modified and 2-modified purine 2'-C-methyl-nucleosides along with their anti-HCV replication activity and cytotoxicity in different cells.

UI MeSH Term Description Entries
D011684 Purine Nucleosides Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES. Purine Nucleoside,Nucleoside, Purine,Nucleosides, Purine
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

Hong-wang Zhang, and Longhu Zhou, and Steven J Coats, and Tamara R McBrayer, and Phillip M Tharnish, and Lavanya Bondada, and Mervi Detorio, and Sarah A Amichai, and Melissa D Johns, and Tony Whitaker, and Raymond F Schinazi
October 2010, Organic letters,
Hong-wang Zhang, and Longhu Zhou, and Steven J Coats, and Tamara R McBrayer, and Phillip M Tharnish, and Lavanya Bondada, and Mervi Detorio, and Sarah A Amichai, and Melissa D Johns, and Tony Whitaker, and Raymond F Schinazi
July 2008, Archives of pharmacal research,
Hong-wang Zhang, and Longhu Zhou, and Steven J Coats, and Tamara R McBrayer, and Phillip M Tharnish, and Lavanya Bondada, and Mervi Detorio, and Sarah A Amichai, and Melissa D Johns, and Tony Whitaker, and Raymond F Schinazi
June 2014, ACS medicinal chemistry letters,
Hong-wang Zhang, and Longhu Zhou, and Steven J Coats, and Tamara R McBrayer, and Phillip M Tharnish, and Lavanya Bondada, and Mervi Detorio, and Sarah A Amichai, and Melissa D Johns, and Tony Whitaker, and Raymond F Schinazi
October 2006, Organic letters,
Hong-wang Zhang, and Longhu Zhou, and Steven J Coats, and Tamara R McBrayer, and Phillip M Tharnish, and Lavanya Bondada, and Mervi Detorio, and Sarah A Amichai, and Melissa D Johns, and Tony Whitaker, and Raymond F Schinazi
July 2010, Bioorganic & medicinal chemistry,
Hong-wang Zhang, and Longhu Zhou, and Steven J Coats, and Tamara R McBrayer, and Phillip M Tharnish, and Lavanya Bondada, and Mervi Detorio, and Sarah A Amichai, and Melissa D Johns, and Tony Whitaker, and Raymond F Schinazi
November 2014, Bioorganic & medicinal chemistry letters,
Hong-wang Zhang, and Longhu Zhou, and Steven J Coats, and Tamara R McBrayer, and Phillip M Tharnish, and Lavanya Bondada, and Mervi Detorio, and Sarah A Amichai, and Melissa D Johns, and Tony Whitaker, and Raymond F Schinazi
July 2004, Bioorganic & medicinal chemistry letters,
Hong-wang Zhang, and Longhu Zhou, and Steven J Coats, and Tamara R McBrayer, and Phillip M Tharnish, and Lavanya Bondada, and Mervi Detorio, and Sarah A Amichai, and Melissa D Johns, and Tony Whitaker, and Raymond F Schinazi
January 2007, Nucleosides, nucleotides & nucleic acids,
Hong-wang Zhang, and Longhu Zhou, and Steven J Coats, and Tamara R McBrayer, and Phillip M Tharnish, and Lavanya Bondada, and Mervi Detorio, and Sarah A Amichai, and Melissa D Johns, and Tony Whitaker, and Raymond F Schinazi
March 2015, Bioorganic & medicinal chemistry letters,
Hong-wang Zhang, and Longhu Zhou, and Steven J Coats, and Tamara R McBrayer, and Phillip M Tharnish, and Lavanya Bondada, and Mervi Detorio, and Sarah A Amichai, and Melissa D Johns, and Tony Whitaker, and Raymond F Schinazi
August 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!